Table 6 Effects of oral administration of optimized nanomatrices (PCD-6) on organ weight of rabbits.

From: Characterization and safety evaluation of highly swellable polymeric nanomatrices for enhanced solubility of acyclovir

Treatment

Heart (g)

Liver (g)

Lung (g))

Kidney (g)

Stomach (g)

Group I (control)

4.51 ± 0.01

74.25 ± 2.41

9.23 ± 0.21

12.31 ± 0.94

12.21 ± 0.65

Group II (test)

4.25 ± 0.02

73.32 ± 2.51

9.25 ± 0.23

12.30 ± 0.93

12.31 ± 0.55

Back to article page